Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
NCT03561922
Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS
Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT
Alpha AMS
Type: Interventional
Status of the trial: Completed
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2018-09-04
- Closing Date: 2019-04-05
Criteria
Children: No
Adults: Yes
Funder Type: industry
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Principal investigators
Other investigators
Workgroups
Retinal Rare Eye Diseases (WG1)
This ERN is supported by:
